Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,845,600 | 1,408,900 | 1,004,100 | 805,600 | 832,200 |
| Marketable Securities | 4,200 | 4,200 | 4,200 | 4,300 | 4,300 |
| Receivables | 1,945,100 | 1,901,500 | 1,904,500 | 1,804,900 | 1,829,200 |
| Inventories | 1,546,800 | 1,487,100 | 1,474,600 | 1,443,300 | 1,517,000 |
| Income taxes - deferred | 181,600 | 180,300 | 182,000 | 182,000 | 197,800 |
| Other current assets | 687,100 | 659,500 | 566,700 | 594,700 | 566,800 |
| TOTAL | $6,210,400 | $5,641,500 | $5,136,100 | $4,834,800 | $4,947,300 |
| Non-Current Assets | |||||
| PPE Net | 1,708,700 | 1,688,800 | 1,685,800 | 1,726,400 | 1,669,900 |
| Intangibles | 19,743,500 | 19,720,400 | 20,005,000 | 20,279,000 | 20,406,000 |
| Other Non-Current Assets | 609,900 | 578,800 | 583,800 | 604,400 | 554,800 |
| TOTAL | $22,062,100 | $21,988,000 | $22,274,600 | $22,609,800 | $22,630,700 |
| Total Assets | $28,272,500 | $27,629,500 | $27,410,700 | $27,444,600 | $27,578,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 672,700 | 648,900 | 660,600 | 641,400 | 684,300 |
| Accrued Expenses | 388,700 | 317,100 | 312,200 | 388,000 | 378,700 |
| TOTAL | $2,453,000 | $2,362,900 | $2,302,800 | $2,093,300 | $2,522,500 |
| Non-Current Liabilities | |||||
| Long Term Debt | 6,717,900 | 6,721,100 | 6,724,400 | 7,031,200 | 7,037,500 |
| Deferred Revenues | 197,900 | 215,200 | 226,100 | 196,500 | 208,400 |
| Other Non-Current Liabilities | 811,700 | 796,901 | 786,400 | 808,201 | 718,200 |
| TOTAL | $9,382,200 | $9,463,801 | $9,508,400 | $9,886,601 | $9,765,000 |
| Total Liabilities | $11,835,200 | $11,826,700 | $11,811,200 | $11,979,900 | $12,287,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 361,367 | 360,516 | 358,921 | 357,625 | 360,215 |
| Common Shares | 419,000 | 418,100 | 416,500 | 413,500 | 410,600 |
| Retained earnings | 8,465,700 | 8,202,600 | 7,979,500 | 7,697,300 | 7,374,800 |
| Other shareholders' equity | -149,900 | -455,900 | -328,800 | -150,200 | -199,900 |
| TOTAL | $16,437,300 | $15,802,800 | $15,599,500 | $15,464,700 | $15,290,500 |
| Total Liabilities And Equity | $28,272,500 | $27,629,500 | $27,410,700 | $27,444,600 | $27,578,000 |